Qualitative research into rheumatic diseases

Date of publication: February 1, 1976


The headquarters of Sandoz in Basle have been carrying out a primary research program on a new drug for the treatment of rheumatic diseases, and are intending to carry out a market research program in the USA, Germany and the UK to explore the potential market for this new drug. In the UK, Sandoz themselves have carried out group discussions which have produced information on basic medical attitudes to this disease area and its drug therapy.

CRAM/Peter Cooper Archive


This is a long description of some author details.

Research Reports

Research Reports

Research Reports

  • PDF
  • This could also be of interest